Skip to main content
. 2022 Apr 27;14(9):2190. doi: 10.3390/cancers14092190
CCA Cholangiocarcinoma
CHCC-CCA Combined hepatocellular-cholangiocarcinoma
DCCA Distal cholangiocarcinoma
FFPE Formalin fixed paraffin embedded
HCC Hepatocellular carcinoma
ICCA Intrahepatic cholangiocarcinoma
MIF Multiplex Immune Fluorescence
NFD Nerve fib er density
OS Overall survival
PCCA Perihilar cholangiocarcinoma
PD-1 Programmed Death receptor
PD-L1 Programmed Death Ligand 1
PD-L2 Programmed Death Ligand 2
PGP 9.5 Protein gene-product 9.5
PNI Perineural invasion
RFS Recurrence-free survival
ROI Region of interest
TME Tumor microenvironment